Compare CNSY & PRHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNSY | PRHI |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 18.7M |
| IPO Year | 2016 | 2015 |
| Metric | CNSY | PRHI |
|---|---|---|
| Price | $1.31 | $7.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $27.75 | N/A |
| AVG Volume (30 Days) | ★ 77.3K | 26.6K |
| Earning Date | 11-17-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.61 | N/A |
| EPS | N/A | ★ 1.66 |
| Revenue | $5,213,000.00 | ★ $43,304,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $414.61 | N/A |
| P/E Ratio | ★ N/A | $4.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.49 | $0.59 |
| 52 Week High | $4.03 | $9.87 |
| Indicator | CNSY | PRHI |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 47.39 |
| Support Level | $1.52 | $4.11 |
| Resistance Level | $2.28 | $7.95 |
| Average True Range (ATR) | 0.16 | 0.69 |
| MACD | 0.04 | -0.06 |
| Stochastic Oscillator | 66.67 | 19.84 |
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.